1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Thrombopenia in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (51.47) | 18.7374 |
1990's | 26 (38.24) | 18.2507 |
2000's | 4 (5.88) | 29.6817 |
2010's | 3 (4.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Z; Jiang, Y; Li, L; Pan, M; Su, EM; Su, X; Sun, P; Sun, W; Wu, H; Yang, J; Yang, X; Zhao, C | 1 |
Byrnes, AP; Smith, JS; Tian, J; Xu, Z | 1 |
Althaus, K; Greinacher, A; Thiele, T | 1 |
Hirasawa, H; Matsuda, K; Nakanishi, K; Oda, S; Shiga, H; Ueno, H | 1 |
Fernandes, CJ; O'Donovan, DJ | 1 |
Lo, GK; Sigouin, CS; Warkentin, TE | 1 |
Greinacher, A | 1 |
Alberton, M; Bussolino, F; Caligaris Cappio, F; Camussi, G; Coda, R; Macchiorlatti, E; Roffinello, C; Segoloni, G; Tetta, C | 1 |
Deguchi, K; Murashima, S; Shirakawa, S | 1 |
Hiller, E; Riess, H | 1 |
Goguel, A; Houbouyan, L; Rosenthal, D; Roussi, J; Toulemonde, F | 1 |
Brain, H; Carter, CJ; Kelton, JG; Powers, PJ; Sheridan, D; Turpie, AG | 1 |
Guay, DR; Richard, A | 1 |
Kalmaz, GD; McDonald, TP | 1 |
High, JA; Namm, DH; Tadepalli, AS | 1 |
Demopoulos, CA; Kapoulas, VM; Tsabikakis, GE | 1 |
Crawford, MH; Fitzpatrick, FA; Hanahan, DJ; McManus, LM; O'Rourke, RA; Pinckard, RN | 1 |
Demopoulos, CA; Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
Hirayama, K; Matsuzaki, T; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
Aishita, H; Fujitani, B; Katsube, N; Sakaguchi, K | 1 |
Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Cruz, HN; de Queiroz-Paulo, M; Kaplan, MA; Martins, MA; Silva, PM | 1 |
Arreto, CD; Bureau, MF; Imaizumi, A; Vargaftig, BB | 1 |
Dodam, JR; Kruse-Elliott, KT; Olson, NC; Whorton, AR | 1 |
Kanagawa, H; Kojima, T; Nishihira, J; Suzuki, H; Taguchi, Y | 1 |
Barbosa-Filho, JM; Barreto, EO; Cordeiro, RS; de Silva, PM; Diaz, BL; Lima, MC; Martins, MA; Pereira, AP; Serra, MF | 1 |
Bailie, MB; Fink, GD; Pearson, JM; Roth, RA | 1 |
Battistini, B; Farmer, P; Johnson, RJ; O'Brien, JG; Sirois, P; Zaharia, F | 1 |
Barbosa-Filho, JM; Castro-Faria-Neto, HC; Cordeiro, RS; Herbert, JM; Tibiriça, E | 1 |
Ashida, Y; Kitao, S; Kobayashi, K; Kyotani, K; Mochizuki, T; Nishizono, K; Scott, MA; Tsuchiya, R; Yamada, T | 1 |
Adamson, LM; Podsiadly, BT; Roberts, TK; Smart, YC; Stanger, JD | 1 |
Aissa, J; Arnoux, B; Benveniste, J; Nathan, N | 1 |
Bernat, A; Gigo, V; Herbert, JM; Lale, A; LaPlace, MC; Le Fur, G; Lespy, L; Maffrand, JP; Savi, P; Valette, G | 1 |
Calvo, IF; da Rocha, FA; de Falco, V; Fernandes, AJ; Jancar, S; Sirois, P | 1 |
Heuer, H; Kempe, R; Meade, CJ | 1 |
Betteridge, KJ; Croy, BA; Johnstone, IB; Rieger, D; Scodras, JM | 1 |
Fenton, J; Gudewicz, PW; Kaplan, JE; Moon, DG; van der Zee, H | 1 |
Ban, C; Hasegawa, M; Ihara, Y; Inamori, K; Itoh, H; Li, XM; Mori, T; Okagaki, A; Sagawa, N | 1 |
Giers, G; Janzarik, H; Kempe, ER; Mueller-Eckhardt, C | 2 |
Ando, M; Matsuura, S; Suginami, H | 1 |
Halonen, M; Lohman, I | 1 |
Farhat, M; Feuerstein, G; Perera, PY; Rabinovici, R; Vogel, SN; Yue, TL | 1 |
Isetta, C; Jourdan, J; Kotaiche, M; Lugrin, D; Roul, C | 1 |
Jackson, SP; Salem, HH | 1 |
Straube, W | 1 |
Amiel, ML; Benveniste, J; Duquenne, C; Testart, J | 1 |
Braquet, P; Lejeune, V; Mencia-Huerta, JM; Touvay, C; Vilain, B | 1 |
Conard, J; Horellou, MH; Lecompte, T; Lecrubier, C; Potevin, F; Samama, M | 1 |
Driscoll, EM; Jackson, CV; Kunkel, SL; Lucchesi, BR; Schumacher, WA | 1 |
Adamus, WS; Lohmann, HF; Meade, CJ | 1 |
Meyers, KM | 1 |
Lian, EC | 1 |
Kelton, JG; Murphy, WG | 1 |
Adnot, S; Braquet, P; Lefort, J; Vargaftig, BB | 1 |
Broquet, C; Coeffier, E; Fichelle, J; Godfroid, JJ; Heymans, F; Jouquey, S; Lebbar, M; Michel, E; Redeuilh, C; Steiner, E | 1 |
Kanaji, K; Okuma, M; Sensaki, S; Sugiyama, T; Uchino, H; Ushikubi, F | 1 |
Adamson, LM; Murdoch, RN; Roberts, TK; Smart, YC; Stanger, JD | 1 |
Castro, HC; Cordeiro, RS; Lima, MC; Martins, MA; Neto, F; Silva, PM; Vargaftig, BB | 1 |
Angle, MJ; McManus, LM; Pinckard, RN; Showell, HJ | 1 |
Lefort, J; Malanchère, E; Pretolani, M; Vargaftig, BB | 1 |
Handley, DA; Saunders, RN; Van Valen, RG | 1 |
Aoki, H; Kohsaka, M; Nishikawa, M; Okamoto, M; Yoshida, K | 1 |
David, R; Pfueller, SL | 1 |
Braquet, P; Desquand, S; Lagente, V; Lefort, J; Randon, J; Touvay, C; Vargaftig, BB; Vilain, B | 1 |
Issekutz, AC; Szpejda, M | 1 |
O'Neill, C | 1 |
Morgan, K; Pockros, PJ; Sandler, RM; Schiffman, S; Seifer, DB; Weiss, LM; Wypych, J | 1 |
8 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Thrombopenia
Article | Year |
---|---|
[Heparin-induced thrombocytopenia].
Topics: Acute Disease; Anticoagulants; Autoantibodies; Heparin; Humans; Platelet Activating Factor; Platelet Count; Platelet Factor 4; Thrombocytopenia | 2010 |
Platelet transfusions in infants with necrotizing enterocolitis.
Topics: Enterocolitis, Necrotizing; Humans; Infant, Newborn; Platelet Activating Factor; Platelet Transfusion; Practice Guidelines as Topic; Thrombocytopenia | 2006 |
[Blood platelet aggregation].
Topics: Arachidonic Acids; Calcium; Glycoproteins; Humans; Lysophosphatidylcholines; Membrane Proteins; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombocythemia, Essential; Thrombocytopenia | 1981 |
Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia.
Topics: Animals; Blood Platelets; Humans; Platelet Activating Factor; Platelet Count; Platelet Membrane Glycoproteins; Purpura, Thrombocytopenic; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thrombocytopenia | 1991 |
[Early embryonal signals].
Topics: Chaperonin 10; Female; Humans; Immunosuppressive Agents; Peptides; Platelet Activating Factor; Pregnancy; Pregnancy Proteins; Pregnancy Tests; Suppressor Factors, Immunologic; Thrombocytopenia | 1989 |
Pathobiology of animal platelets.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclic AMP; Endotoxins; Epinephrine; Epoprostenol; Glycoproteins; Platelet Activating Factor; Platelet Aggregation; Thrombocytopenia; von Willebrand Factor | 1985 |
Pathogenesis of thrombotic thrombocytopenic purpura.
Topics: Adult; Blood Platelets; Blood Proteins; Capillaries; Child, Preschool; Endothelium; Epoprostenol; Female; Humans; Microcirculation; Platelet Activating Factor; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombosis; von Willebrand Factor | 1987 |
Acute thrombocytopenia and thrombosis. Heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura.
Topics: Blood Coagulation Factors; Endothelium, Vascular; Epoprostenol; Heparin; Humans; Platelet Activating Factor; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; von Willebrand Factor | 1987 |
60 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Thrombopenia
Article | Year |
---|---|
Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice.
Topics: Animals; Bronchoalveolar Lavage; Chemokine CXCL2; Cystic Fibrosis Transmembrane Conductance Regulator; Escherichia coli; Lipopolysaccharides; Lipoxins; Mice, Inbred CFTR; Mutation; P-Selectin; Platelet Activating Factor; Platelet Count; Pneumonia; Thrombocytopenia | 2014 |
Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.
Topics: Adenoviridae; Animals; Cytokines; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Lipids; Mononuclear Phagocyte System; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock; Signal Transduction; Thrombocytopenia | 2010 |
Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure.
Topics: Adult; Aged; Blood Coagulation; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Interleukin-6; Leukocyte Elastase; Male; Middle Aged; Multiple Organ Failure; Platelet Activating Factor; Platelet Count; Retrospective Studies; Sepsis; Thrombocytopenia; Thrombomodulin | 2002 |
What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
Topics: Aged; Aged, 80 and over; Autoantibodies; Diagnosis, Differential; Female; Heparin; Humans; Male; Middle Aged; Platelet Activating Factor; Survival Analysis; Thrombocytopenia; Thrombosis | 2007 |
Too many hits in HIT?
Topics: Autoantibodies; Heparin; Humans; Platelet Activating Factor; Thrombocytopenia | 2007 |
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.
Topics: Agranulocytosis; Animals; Antigen-Antibody Complex; Cell Aggregation; Epoprostenol; Neutropenia; Neutrophils; Platelet Activating Factor; Prostaglandins; Rabbits; Thrombocytopenia | 1983 |
Heparin and thrombocytopenia.
Topics: Blood Coagulation Factors; Heparin; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombocytopenia | 1984 |
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia].
Topics: Adult; Blood Coagulation Factors; Female; Heparin; Humans; Molecular Weight; Platelet Activating Factor; Platelet Aggregation; Pulmonary Embolism; Thrombocytopenia | 1983 |
Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.
Topics: Adult; Aged; Blood Coagulation Factors; Female; Heparin; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Thrombocytopenia | 1984 |
Heparin-induced thrombocytopenia--association with a platelet aggregating factor and cross-sensitivity to bovine and porcine heparin.
Topics: Adult; Animals; Blood Coagulation Factors; Blood Platelets; Cattle; Heparin; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Swine; Thrombocytopenia | 1984 |
Effects of thrombopoietin on the number and diameter of marrow megakaryocytes of mice.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Cell Count; Glycoproteins; Immune Sera; Male; Megakaryocytes; Mice; Mice, Inbred C3H; Platelet Activating Factor; Platelet Count; Rabbits; Thrombocytopenia; Thrombopoietin | 1983 |
Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine.
Topics: Anesthesia; Animals; Blood Coagulation; Blood Platelets; Calcium Chloride; Cats; Dogs; Ether; Guinea Pigs; Heart Rate; Horses; Humans; Hypotension; Lysophosphatidylcholines; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Serotonin; Species Specificity; Thrombocytopenia | 1982 |
Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs.
Topics: Anaphylaxis; Animals; Dose-Response Relationship, Drug; Female; Guinea Pigs; Infusions, Parenteral; Leukocyte Count; Leukopenia; Lysophosphatidylcholines; Male; Papio; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia | 1981 |
Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
Topics: Animals; Blood Cell Count; Blood Coagulation Factors; Blood Proteins; Hematocrit; Infusions, Parenteral; Lysophosphatidylcholines; Neutropenia; Papio; Platelet Activating Factor; Platelet Factor 4; Species Specificity; Thrombocytopenia; Thromboxane B2; Thromboxanes | 1981 |
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
Topics: Animals; Basophils; Blood Platelets; Dose-Response Relationship, Drug; Female; Infusions, Parenteral; Leukocyte Count; Lysophosphatidylcholines; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Factor 4; Rabbits; Thrombocytopenia | 1980 |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Cells; Blood Pressure; Cardiac Output; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypotension; Indomethacin; Injections, Intravenous; Leukopenia; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Starfish; Tachyphylaxis; Thrombocytopenia; Vascular Resistance; Venoms | 1994 |
Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
Topics: Adenosine Diphosphate; alpha-Cyclodextrins; Animals; Arachidonic Acid; Blood Coagulation Factors; Blood Platelets; Blood Pressure; Collagen; Cyclodextrins; Dogs; Epoprostenol; Female; Fibrinolytic Agents; Humans; Macaca; Male; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Rabbits; Rats; Rats, Wistar; Species Specificity; Thrombocytopenia | 1993 |
Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity.
Topics: Animals; Furans; Lignans; Lignin; Male; Molecular Structure; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Wistar; Thrombocytopenia | 1993 |
Pharmacological differentiation by pertussis toxin of the in vivo acute responses to fMLP and PAF in guinea-pig lungs.
Topics: Acetylcholine; Animals; Blood Platelets; Blood Volume; Bronchoconstriction; Capillary Permeability; Female; Guinea Pigs; Leukocytes; Leukopenia; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Pertussis Toxin; Platelet Activating Factor; Thrombocytopenia; Virulence Factors, Bordetella | 1993 |
Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs.
Topics: Animals; Blood Platelets; Calcimycin; GTP-Binding Proteins; Hemodynamics; Indomethacin; Injections, Intravenous; Lung; Pertussis Toxin; Phosphorylation; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Sodium Chloride; Swine; Thrombocytopenia; Thromboxane B2; Time Factors; Vasoconstriction; Virulence Factors, Bordetella | 1993 |
Evidence for the production of platelet-activating factor by murine embryos and its putative role in the maternal physiology.
Topics: Animals; Culture Techniques; Embryo, Mammalian; Female; Maternal-Fetal Exchange; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Rabbits; Thrombocytopenia | 1995 |
Clinical studies of IL-11, new platelet growth factor, presented.
Topics: Animals; Breast Neoplasms; Clinical Trials as Topic; Hematopoiesis; Humans; Interleukin-11; Neoplasms; Platelet Activating Factor; Recombinant Proteins; Sepsis; Thrombocytopenia | 1997 |
Anti-allergic properties of the natural PAF antagonist yangambin.
Topics: Animals; Anti-Allergic Agents; Eosinophils; Female; Furans; Leukocytosis; Lignans; Male; Neutrophils; Plant Extracts; Platelet Activating Factor; Pleurisy; Rats; Rats, Wistar; Thrombocytopenia | 1997 |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
Topics: Administration, Oral; Alanine Transaminase; Animals; Azepines; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Hydroxyurea; Injections, Intraperitoneal; Injections, Intravenous; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Diseases; Necrosis; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombocytopenia; Triazoles | 1997 |
Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats.
Topics: Animals; Antifibrinolytic Agents; Aprotinin; Bronchi; Capillary Permeability; Male; Neutropenia; Platelet Activating Factor; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Thrombocytopenia; Trachea; Tranexamic Acid; Trypsin Inhibitors | 1997 |
Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin.
Topics: Animals; Blood Platelets; Furans; Guinea Pigs; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes; Leukopenia; Lignans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Burst; Thiazoles; Thrombocytopenia; Tumor Necrosis Factor-alpha | 1997 |
Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Topics: Animals; Blood Coagulation Tests; Dog Diseases; Dogs; Endotoxemia; Female; Isoquinolines; Leukocyte Count; Lipopolysaccharides; Male; Neutropenia; Pilot Projects; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Count; Pyridinium Compounds; Radioimmunoassay; Tetrahydroisoquinolines; Thrombocytopenia | 1999 |
Prefertilization treatment of mice with platelet activating factor affects pregnancy.
Topics: Animals; Embryo Implantation; Embryonic and Fetal Development; Female; Fertilization; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Platelet Activating Factor; Pregnancy; Pregnancy, Animal; Thrombocytopenia | 1992 |
Role of paf-acether in protamine-induced thrombocytopenia in rabbits.
Topics: Animals; Heparin Antagonists; Platelet Activating Factor; Protamines; Rabbits; Thrombocytopenia | 1992 |
Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Topics: Animals; Azepines; Blood Platelets; Bronchoconstriction; Guinea Pigs; Humans; Injections, Intravenous; Leukopenia; Male; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thrombocytopenia; Triazoles | 1991 |
Mechanisms of thrombocytopenia in the acute phase of antigen-induced arthritis in rabbits.
Topics: Animals; Arthritis, Experimental; Diterpenes; Econazole; Female; Ginkgolides; Indoles; Indomethacin; Lactones; Male; Platelet Activating Factor; Rabbits; Synovial Fluid; Thrombocytopenia; Thromboxane A2; Thromboxane B2 | 1991 |
Failure to detect platelet-activating factor using the splenectomized mouse bioassay.
Topics: Adenosine Diphosphate; Animals; Biological Assay; Blood Platelets; Cattle; Horses; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Splenectomy; Thrombin; Thrombocytopenia | 1991 |
Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086.
Topics: Animals; Azepines; Carbon Dioxide; Cell Adhesion; Leukocyte Count; Leukopenia; Platelet Activating Factor; Sheep; Thrombin; Thrombocytopenia; Thromboxane B2; Triazoles | 1991 |
The involvement of platelet-activating factor in thrombocytopenia and follicular rupture during gonadotropin-induced superovulation in immature rats.
Topics: Animals; Azepines; Chorionic Gonadotropin; Female; Gonadotropins, Equine; Indomethacin; Ovulation; Ovulation Induction; Platelet Activating Factor; Platelet Activation; Platelet Count; Rats; Rats, Inbred Strains; Superovulation; Thrombocytopenia; Triazoles; Vena Cava, Inferior | 1991 |
PAF-acether-antagonist WEB 2086 for treatment of chronic idiopathic thrombocytopenia.
Topics: Azepines; Chronic Disease; Drug Evaluation; Humans; Platelet Activating Factor; Thrombocytopenia; Triazoles | 1990 |
Pregnancy suppression by a structurally related antagonist for platelet activating factor, CV-6209, in mice.
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Embryonic and Fetal Development; Embryonic Development; Female; Mice; Mice, Inbred ICR; Platelet Activating Factor; Platelet Count; Pregnancy; Pregnancy, Animal; Pyridinium Compounds; Thrombocytopenia; Time Factors | 1990 |
Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
Topics: Anaphylaxis; Animals; Azepines; Bronchial Spasm; Hypotension; Immunoglobulin E; Leukopenia; Lung; Platelet Activating Factor; Rabbits; Thrombocytopenia; Triazoles | 1990 |
Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.
Topics: Adult; Aged; Autoimmune Diseases; Azepines; Chronic Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Prospective Studies; Thrombocytopenia; Triazoles | 1990 |
Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
Topics: Animals; Azepines; Blood Cell Count; Endotoxins; Leukopenia; Male; Platelet Activating Factor; Rabbits; Thrombocytopenia; Thromboxane B2; Triazoles | 1990 |
[Thrombocytopenia induced by heparin and cardiac surgery with extracorporeal circulation].
Topics: Blood Coagulation Factors; Cardiac Surgical Procedures; Extracorporeal Circulation; Female; Heparin; Humans; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Postoperative Period; Thrombocytopenia; Vitamin K | 1990 |
Platelet aggregating activity in the plasma of patients with established thrombosis.
Topics: Adult; Aged; Aspirin; Benzamidines; Blood Coagulation Factors; Edetic Acid; Humans; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Thrombocytopenia; Thrombosis; Time Factors | 1989 |
Platelet aggregating activity in human embryo culture media free of PAF-acether.
Topics: Animals; Biological Assay; Cells, Cultured; Culture Media; Embryo, Mammalian; Humans; Mice; Platelet Activating Factor; Platelet Aggregation; Thrombocytopenia | 1989 |
Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig.
Topics: Animals; Antigens; Bronchial Provocation Tests; Bronchial Spasm; Cyclosporins; Diterpenes; Ginkgolides; Guinea Pigs; Immunization, Passive; In Vitro Techniques; Lactones; Leukopenia; Male; Platelet Activating Factor; Thrombocytopenia | 1989 |
[Platelet aggregation tests in 26 cases of heparin-induced thrombopenia. Methodological, diagnostic problems and therapeutic aspects].
Topics: Adult; Aged; Blood Coagulation Factors; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Thrombocytopenia | 1987 |
Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine.
Topics: Animals; Aspirin; Coronary Circulation; Coronary Vessels; Diphenhydramine; Dogs; Histamine H1 Antagonists; Male; Methacholine Compounds; Methysergide; Nitroglycerin; Platelet Activating Factor; Thrombocytopenia; Vasodilation | 1986 |
Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086.
Topics: Administration, Oral; Azepines; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Count; Thrombocytopenia; Triazines; Triazoles | 1988 |
Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig.
Topics: Animals; Diterpenes; Female; Ginkgolides; Guinea Pigs; Hypotension; Lactones; Male; Plant Extracts; Platelet Activating Factor; Shock, Septic; Thrombocytopenia | 1986 |
Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity.
Topics: Animals; Blood Pressure; Bronchi; Chemical Phenomena; Chemistry; Constriction, Pathologic; Guinea Pigs; Male; Molecular Conformation; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thrombocytopenia | 1987 |
A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia.
Topics: Autoimmune Diseases; Blood Coagulation Factors; Blood Platelet Disorders; Collagen; Female; Humans; Immunoglobulin G; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Purpura, Thrombocytopenic; Thrombocytopenia; Thromboxane B2 | 1987 |
Mechanistic studies of early pregnancy associated thrombocytopenia (EPAT) in the mouse.
Topics: Animals; Blood Platelets; Embryonic Development; Female; Mice; Platelet Activating Factor; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia | 1987 |
Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Dexamethasone; Edema; Indomethacin; Inflammation; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thrombocytopenia | 1987 |
Ontogeny of the responsiveness to intravenous platelet-activating factor.
Topics: Aging; Anaphylaxis; Animals; Animals, Newborn; Female; Leukopenia; Lung; Male; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Rabbits; Thrombocytopenia; Thromboxane B2 | 1987 |
Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Topics: Anaphylaxis; Animals; Azepines; Female; Guinea Pigs; Histamine; In Vitro Techniques; Indicators and Reagents; Leukopenia; Male; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Radioimmunoassay; Respiratory System; Spectrometry, Fluorescence; Thrombocytopenia; Thromboxane B2; Triazines; Triazoles | 1987 |
Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119.
Topics: Animals; Cebus; Indomethacin; Lung; Macaca mulatta; Male; Papio; Platelet Activating Factor; Platelet Aggregation; Thiazoles; Thrombocytopenia; Thromboxane B2 | 1986 |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF.
Topics: Animals; Cell Count; Depression, Chemical; Drug Interactions; Endotoxins; Indoles; Injections, Intravenous; Leukopenia; Male; Piperazines; Platelet Activating Factor; Rabbits; Thrombocytopenia; Time Factors | 1986 |
Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia.
Topics: Antibody Specificity; Blood Coagulation Factors; Blood Platelets; Epinephrine; Heparin; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombocytopenia | 1986 |
Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
Topics: Anaphylaxis; Animals; Bronchi; Diterpenes; Ginkgolides; Guinea Pigs; Lactones; Plant Extracts; Platelet Activating Factor; Propranolol; Pyrilamine; Thrombocytopenia | 1986 |
Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Topics: Acute Disease; Animals; Blood Platelets; Capillary Permeability; Cell Movement; Inflammation; Leukocytes; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Regional Blood Flow; Serum Albumin; Skin; Thiazoles; Thrombocytopenia | 1986 |
Examination of the causes of early pregnancy-associated thrombocytopenia in mice.
Topics: Animals; Bleeding Time; Blood Coagulation; Culture Media; Embryonic Development; Female; Genotype; Mice; Mice, Inbred Strains; Parthenogenesis; Platelet Activating Factor; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, Animal; Pseudopregnancy; Splenectomy; Thrombocytopenia | 1985 |
Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG.
Topics: Blood Coagulation Factors; Chromatography, Affinity; Female; Heparin; Humans; Immunoglobulin G; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Sepharose; Thrombocytopenia; Thrombosis | 1985 |